Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTyratech Regulatory News (TYR)

  • There is currently no data for TYR

Clarke Partnership

10 Sep 2009 07:00

RNS Number : 8143Y
TyraTech, Inc.
10 September 2009
 



For immediate release

10 September 2009

TYRATECH, INC.

("TyraTech" or "the Company")

Partnership Agreement with Clarke Mosquito Control

 

for mosquito products

~ Channel to market established via leading US company ~

TyraTech, Inc. (AIM: TYR), a leading independent novel clean technology company for human, animal and environmental health, is pleased to announce that it has today signed a strategic partnership agreement (the "Agreement") with Clarke Mosquito Control ("Clarke"), the leading provider of professional contract mosquito services and products in the US. 

Under the Agreement, Clarke will have exclusive rights to develop, market and sell products exploiting the TyraTech Natural technology for the US vector control market, along with non-exclusive access to these products in a range of other countries. Clarke will fund the development of these new products.

The Agreement gives TyraTech the right to use the products developed by Clarke using TyraTech technology in all remaining territories and in other market segments for all territories. TyraTech will supply a pipeline of natural active ingredients that have been engineered by TyraTech to deliver the next generation of natural products and new innovative chemistries that are currently not in the marketplace. Clarke, a family owned business, has been at the forefront of the US mosquito control industry since 1946, offering services, products and equipment that aid the control of mosquito populations. Clarke is the market leader in the US vector control industry and is also internationally active with established businesses.

Commenting on the announcement, Douglas Armstrong Ph.D., Chief Executive Officer of TyraTech, said: "By partnering with Clarke to develop our TyraTech Nature's technology for mosquito control applications, TyraTech is working with the leading US mosquito control company and will benefit from their substantial expertise and established sales channels in this market. TyraTech's Nature's technology based products and its EXTEND product range, should bring a unique profile to the mosquito control market."

"Our Agreement with Clarke builds further partnering momentum for TyraTech and validates our business model which brings together multiple revenue streams by working with the best partners that have established expertise in their market sector, as well as accessing appropriate markets directly." 

For further information please contact:

TyraTech Inc.

Douglas Armstrong Ph.D., Chief Executive Officer +1 (321) 409 7723

Keith Bigsby, Chief Financial Officer +1 (321) 409 7714

www.tyratech.com

Nomura Code Securities

Charles Walker/Clare Terlouw +44 (0)20 7776 1200

www.nomuracode.com

Buchanan Communications

MaryߛJane Elliott / Lisa Baderoon +44 (0)20 7466 5000 / Catherine Breen / Stasa Filiplic

www.buchanan.uk.com

 

About Clarke Mosquito Control

Based in IllinoisUSAClarke is a global environmental products and services company whose mission is to make communities around the world more livable, safe and comfortable. This is done by pioneering, developing and delivering environmentally responsible mosquito control and aquatic services to help prevent disease, control nuisances and create healthy waterwayswww.clarke.com

About TyraTech

TyraTech was formed in 2004 to develop and commercialise products for the control of invertebrate pests and pathogens using the Company's proprietary technology. TyraTech, which already has a product on the market, is positioned for human health, animal health and pesticide market opportunities which total over $32 billion globally. TyraTech's technology provides the Company with a wide variety of product and business opportunities in many markets and geographic regions. The differentiating feature of these products is the potential to have a combined level of potency and safety that other invertebrate control products are unable to offer. TyraTech's platform brings many of the principles of drug discovery and development to the fields of insecticides and parasiticides. By targeting specific chemoreceptors that are found in invertebrates but not in humans and animals, TyraTech can produce products that use natural plant derived compounds targeting these receptors.

 

TyraTech's plan for the use of its technology is to develop selected proprietary active ingredients which can then be used across a wide variety of market segments, either by development partners or by TyraTech itself. TyraTech already has products or partnerships in the areas of professional and horticultural insect control, and for an insect/mosquito repellent. TyraTech also has an innovative partnership with Kraft to use its natural oils to develop functional foods for improving the health of the more than 2 billion people worldwide subject to intestinal parasitic infections.

 

TyraTech also has a separate technology with associated intellectual property that is the basis for the Sustainable Solutions business. This technology has been incorporated into specialised dairy farm equipment for processing cattle manure waste to a usable material for TyraTech to sell as a commercial plant growing medium. For more information please visit www.tyratech.com.

 

TyraTech Natural

 

TyraTech Natural products contain a mixture of active ingredients which are derived from plant oils. The components and relative percentages have been selected using the company's proprietary platform technology for maximum synergistic activity against the targeted insect or parasite.

 

The TyraTech Natural components make these products suitable for:

human and animal treatments; 

use in areas with heavy human contact; 

use in areas where food is transported, stored or processed; 

markets which desire all-natural active ingredients; and 

overcoming pesticide resistance by insects. 

 

TyraTech EXTEND

 

TyraTech EXTEND products are based on a synergistic combination of selected natural active ingredients with selected synthetic pesticide compounds..

 

TyraTech EXTEND products are intended to expand the market and partnering opportunity for TyraTech, by:

reducing the concentration of active ingredients needed to achieve a net efficiency, with associated improved profit margin; 

extending useful life of existing synthetic components by overcoming pesticide resistance by insects; 

extending patent life for synthetic compounds; 

providing highly potent pesticides for use in outside areas that do not have heavy human contact (such as farm fields, or wide-spread rural spraying). 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
AGRCKCKKDBKBDCK
Date   Source Headline
27th Apr 20129:59 amRNSAward of Share Options
20th Apr 20122:46 pmRNSHolding(s) in Company
18th Apr 20121:03 pmRNSHolding(s) in Company
10th Apr 20123:00 pmRNSDirector Dealing, Issue of Shares and AR Amendment
30th Mar 20122:36 pmRNSDirectorate Change
15th Mar 20125:00 pmRNSHolding(s) in Company
7th Mar 20122:04 pmRNSHolding(s) in Company
6th Mar 20127:00 amRNSIssue of Equity
5th Mar 20125:26 pmRNSHolding(s) in Company
2nd Mar 201211:42 amRNSHolding(s) in Company
27th Feb 20125:15 pmRNSResult of Special Meeting
17th Feb 201212:43 pmRNSAppointment of Joint Broker
14th Feb 20121:00 pmRNSProposed Placing and Subscription
2nd Feb 20129:00 amRNSTrading Update
1st Feb 20127:00 amRNSChange of Adviser
11th Jan 20127:00 amRNSTrading Update
7th Dec 201110:44 amRNSReplacement: Migration of Shares
7th Dec 20117:00 amRNSMigration of Shares and Block Listing Review
26th Oct 20117:00 amRNSCourt ruling in favour of TyraTech
25th Oct 20117:00 amRNSAdvisor appointed to seek Product Sale Partners
19th Oct 20117:00 amRNSTyraTech appoints a Head of European Operations
7th Oct 20117:00 amRNSMigration of shares
23rd Aug 20117:00 amRNSGerman Registrations for Three Aerosol Products
17th Aug 20117:00 amRNSDirector/PDMR Shareholding
11th Aug 20113:07 pmRNSDirector/PDMR Shareholding
11th Aug 20117:08 amRNSInterim Results
27th Jul 20115:38 pmRNSResult of AGM
30th Jun 20117:00 amRNSPosting of Annual Report and Accounts 2010
24th Jun 201112:01 pmRNSDirector/PDMR Shareholding
10th Jun 20115:55 pmRNSDirector/PDMR Shareholding
10th Jun 20115:46 pmRNSDirector/PDMR Shareholding
10th Jun 20117:00 amRNSPreliminary Results
7th Jun 20116:08 pmRNSDirector/PDMR Shareholding
1st Jun 20118:00 amRNSCourt ruling in favour of TyraTech
27th May 20114:56 pmRNSDirectorate Change
1st Mar 20118:00 amRNSShare migration to unrestricted trading line
25th Feb 20118:00 amRNSBlock listing application
4th Jan 20119:01 amRNSHolding(s) in Company
29th Dec 20102:23 pmRNSHolding(s) in Company
21st Dec 20102:26 pmRNSMajor Shareholdings
21st Dec 20109:00 amRNSIssue of Equity
30th Nov 20108:16 amRNSHolding(s) in Company
12th Nov 20103:31 pmRNSDirector Remuneration & Treasury Share Readmission
26th Oct 20102:59 pmRNSShare Migration to Unrestricted Trading Line
26th Oct 20102:59 pmRNSShare Migration to Unrestricted Trading Line
21st Oct 20103:22 pmRNSAward of Share Options
21st Oct 20103:22 pmRNSAward of Share Options
20th Oct 20107:00 amRNSSupply Agreement Signed With Terminix
6th Oct 20107:00 amRNSSignificant reorder from Terminix
4th Oct 20107:00 amRNSCorporate Broker Change

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.